SCHEMBL7938671

SCHEMBL7938671

Cc1cc(CNCC2CCCCC2)on1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.44
PDE10A Q9Y233 1/20 0.42
VHL P40337 1/20 0.42
ALDH1A1 P00352 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
IGF1R P08069 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
S1PR1 P21453 2/20 0.37
S1PR3 Q99500 2/20 0.37
TSHR P16473 1/20 0.37
XBP1 P17861 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GAA P10253 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1320408 0.77 VHL (0.41) EPHX2PDE10AVHLNPC1RAB9A
SCHEMBL1320181 0.74 VHL (0.41) EPHX2PDE10AVHLALDH1A1S1PR1
SCHEMBL6409949 0.73 EPHX2 (0.57) EPHX2ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL2258741 0.73 VHL (0.44) EPHX2PDE10AVHLALDH1A1SMN1; SMN2
SCHEMBL7992354 0.72 VHL (0.44) EPHX2PDE10AVHLALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL4305870 0.72 VHL (0.42) EPHX2PDE10AVHLALDH1A1SMN1; SMN2
SCHEMBL1320569 0.71 S1PR1 (0.40) EPHX2PDE10AVHLALDH1A1NPC1
SCHEMBL14947414 0.70 POLB (0.47) EPHX2PDE10AVHLALDH1A1SMN1; SMN2
SCHEMBL16232505 0.70 VHL (0.42) EPHX2VHLALDH1A1NPC1RAB9A
SCHEMBL14364098 0.70 NPC1 (0.49) VHLALDH1A1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010035032-A1 CALCIUM ION CHANNEL MODULATORS & USES THEREOF LECTUS THERAPEUTICS LIMITED (GB) 2010-04-01 WO disclosed
WO-2009133387-A1 INDOLE- 3 -GLYOXYLAMIDE DERIVATIVES FOR USE AS CALCIUM ION CHANNEL MODULATORS LECTUS THERAPEUTICS LIMITED (GB) 2009-11-05 WO disclosed